New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
10:03 EDTNLNK, XOMA, BIG, PANW, SWYOptions with decreasing implied volatility: NLNK XOMA BIG PANW SWY
News For NLNK;XOMA;BIG;PANW;SWY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 14, 2014
10:10 EDTNLNKNIH director says supporting BioCryst, Chimerix Ebola treatments
Subscribe for More Information
09:04 EDTNLNKChinese company says drug can cure Ebola, Reuters reports
Subscribe for More Information
October 13, 2014
11:15 EDTNLNKEbola vaccine licensed to NewLink begins human trials
Canada's Minister of Health announced the launch of Phase 1 clinical trials for Canada's Ebola vaccine, which was developed by scientists at the Public Health Agency of Canada's National Microbiology Laboratory. The Canadian government owns the intellectual property associated with this vaccine and has licensed the rights to NewLink Genetics through its wholly owned subsidiary BioProtection Systems. The Phase 1 clinical trial will test the vaccine on a small group of people to assess its safety, determine the appropriate dosage and identify any side effects.
October 12, 2014
19:26 EDTNLNKPatient being evaluated at Boston hospital for possible Ebola, Boston Globe says
Health officials say that a man that recently traveled to Liberia is being assessed at Beth Israel Deaconess hospital in Boston for the Ebola virus, the Boston Globe says. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
19:12 EDTNLNKCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
17:34 EDTPANWJPMorgan to double spending on cybersecurity over next five years, WSJ says
Subscribe for More Information
14:18 EDTNLNKNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTNLNKTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
October 10, 2014
13:01 EDTXOMAXOMA management to meet with Maxim
Subscribe for More Information
10:54 EDTNLNKMapp looking to up production of experimental Ebola treatment, WSJ says
Mapp Biopharmaceutical is aiming to broaden the manufacturing of its experimental Ebola treatment, ZMapp, according to The Wall Street Journal, citing comments from the company. Mapp said that the treatment was given to a few infected individuals prior to supplies running out two months ago. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
October 9, 2014
14:55 EDTNLNKHospital says deputy showing no signs of Ebola, AP reports
Subscribe for More Information
14:24 EDTNLNKCDC head compares Ebola to AIDS, Washington Post says
Subscribe for More Information
14:13 EDTNLNKFirst Ebola vaccine trial in West Africa started, NBC News reports
Subscribe for More Information
12:06 EDTNLNKLakeland Industries continues surge amid Ebola fears
Subscribe for More Information
09:08 EDTXOMAXOMA initiates dosing in XOMA 358 Phase 1 study
Subscribe for More Information
06:40 EDTPANWSource of JPMorgan cyberattack still unclear, NY Times says
The source of the cyberattack on JPMorgan (JPM) and other U.S. financial institutions this summer is still unclear, according to The New York Times. The hackers may have tried to hit about a dozen financial institutions , and E-Trade(ETFC) and Fidelity Investments may have been victimized in some way, the newspaper stated, citing an unnamed source who was briefed on the matter. At least five other banks, including Citigroup (C), HSBC (HBC) and Regions Financial (RF), discovered that one of the web addresses used by those who hacked JPMorgan tried to penetrate their systems, The Times quoted unnamed sources briefed on the matter as saying. Publicly traded companies in the space include Barracuda Networks (CUDA), Check Point (CHKP), F5 Networks (FFIV), FireEye (FEYE), Fortinet (FTNT), Imperva (IMPV), Palo Alto (PANW), Proofpoint (PFPT), Qualys (QLYS) and Symantec (SYMC). Reference Link
October 8, 2014
15:25 EDTSWYNotable companies reporting after market close
Subscribe for More Information
12:12 EDTPANWPalo Alto management to meet with Oppenheimer
Meeting to be held in Canada on October 14 hosted by Oppenheimer.
07:58 EDTPANWPalo Alto price target raised to $120 from $105 at Pacific Crest
Subscribe for More Information
07:52 EDTPANWPalo Alto has positive catalysts, says Wells Fargo
After meeting with Palo Alto's management, Wells Fargo thinks the company's new endpoint security product could increase its long-term revenue growth by five or six percentage points. The firm expects the company's product revenue to be boosted by an existing customer refresh cycle in 2015, and Wells is confident in the company's service revenue outlook. It raised its price target on the name to $112-$129 from $113-$120 and keeps an Outperform rating on the shares.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use